Kidney–heart crosstalk: the extracellular vesicles connection
Nephrology Dialysis Transplantation · 2026
DOI: 10.1093/ndt/gfag022 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Carmine Zoccali und 14 weiteren Autor:innen. Beteiligte Einrichtung: Renal Research Institute, New York, USA. Hauptthemen laut MEDLINE: Extracellular Vesicles, Renal Insufficiency, Chronic, Cardiovascular Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chronic kidney disease (CKD) is a major public health concern, closely linked to an increased risk of cardiovascular disease (CVD), which remains the leading cause of morbidity and mortality in this population. While traditional risk factors such as hypertension and diabetes are prevalent in CKD, disease-specific mechanisms—including chronic inflammation, oxidative stress, mineral disturbances and the accumulation of uraemic toxins—further amplify cardiovascular vulnerability. In CKD, both the abundance and molecular cargo of circulating extracellular vesicles (EVs) are altered, reflecting the underlying metabolic and inflammatory milieu. These EVs propagate endothelial dysfunction, vascular calcification, inflammation, thrombosis and cardiac remodelling by transferring bioactive molecules such as proteins and microRNAs to target cells. Emerging evidence suggests that EVs not only serve as biomarkers for early detection and risk stratification of CVD in CKD but may also represent novel therapeutic targets. Preclinical studies demonstrate the potential of stem cell–derived and engineered EVs to promote cardiac repair and modulate pathological signalling. However, translation into clinical practice requires rigorous standardization, safety validation and well-designed human trials. This review synthesizes current knowledge on the mechanisms by which EVs bridge renal dysfunction and cardiovascular pathology, discusses their utility as biomarkers and outlines a research agenda for harnessing their therapeutic potential in CKD-associated CVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Renal Research Institute, New York, USA.
- Institute of Molecular Biology and Genetics (Biogem), Ariano Irpino, Italy.
- Associazione Ipertensione Nefrologia Trapianto (IPNET), c/o Nefrologia, Grande Ospedale Metropolitano, Reggio Calabria, Italy.
- Institut de Recerca Biomedica de Lleida - Fundacio Dr Pifarre, IRBLleida, Lleida, Spain.
- RICORS 2040, Instituto de Salud Carlos III, Madrid, Spain.
- Department of Internal Medicine, section Nephrology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
ORCID-Profile: Carmine Zoccali
Zitieren
APA
Zoccali, C., Valdivielso, J. M., Vogt, L., Ntounousi, E., Iatridi, F., Piko, N., Fernández-Fernández, B., Ortiz, A., Chinnappa, S., Mark, P. B., Kanbay, M., Mallamaci, F., Wiecek, A., Bussolati, B., & Bijkerk, R. (2026). Kidney–heart crosstalk: the extracellular vesicles connection. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag022
Vancouver
Zoccali C, Valdivielso JM, Vogt L, Ntounousi E, Iatridi F, Piko N, et al. Kidney–heart crosstalk: the extracellular vesicles connection. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfag022
BibTeX
@article{Zoccali2026,
author = {Zoccali, Carmine and Valdivielso, José Manuel and Vogt, Liffert and Ntounousi, Evangelia and Iatridi, Fotini and Piko, Nejc and Fernández-Fernández, Beatriz and Ortiz, Alberto and Chinnappa, Shanmugakumar and Mark, Patrick B and Kanbay, Mehmet and Mallamaci, Francesca and Wiecek, Andrzej and Bussolati, Benedetta and Bijkerk, Roel},
title = {Kidney–heart crosstalk: the extracellular vesicles connection},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfag022}
}
EUVIMED